PDCD1 and cervical carcinoma: More specifically, HPV oncoproteins E5 and E6/E7 can activate the PD-1/PD-L1 axis; hence, further research is required to elucidate the association between HPV status and the efficacy of PD-1/PD-L1 inhibitors and/or other inhibitors related to cell death program in cervical cancer.